Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hay LS"'
Autor:
Jani D; Bioanalytical and Molecular Assays, Moderna, 325 Binney Street, Cambridge, Massachusetts, USA. darshana.jani@modernatx.com., Gunsior M; Translational Sciences, Astria Therapeutics, Boston, Massachusetts, USA., Marsden R; Revelation Biosciences, San Diego, California, USA., Cowan KJ; Drug Metabolism & Pharmacokinetics, New Biological Entities, Merck KGaA, Darmstadt, Germany., Irvin SC; Bioanalytical Sciences, Regeneron Pharmaceuticals, Tarrytown, New York, USA., Hay LS; Bioanalytical Lab, PPD Clinical Research Business, Thermo Fisher Scientific, Richmond, Virginia, USA., Ward B; Bioanalytical Lab, PPD Clinical Research Business, Thermo Fisher Scientific, Richmond, Virginia, USA., Armstrong L; Bioanalytical Operations, BioAgilytix Labs, Durham, North Carolina, USA., Azadeh M; Bioanalytical and Biomarker Development, Ultragenyx Pharmaceutical, Inc, Novato, California, USA., Cao L; Biomarker and BioAnalytical Sciences, Sangamo Therapeutics, Brisbane, California, USA., Carmean R; Bioanalytical Lab, PPD Clinical Research Business, Thermo Fisher Scientific, Richmond, Virginia, USA., DelCarpini J; Bioanalytical Sciences, Moderna, Cambridge, Massachusetts, USA., Dholakiya SL; Non-Clinical Disposition and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA., Hays A; Scientific Office, BioAgilytix Labs, Durham, North Carolina, USA., Hosback S; Research and Clinical Bioanalytics, CSL, Melbourne, Australia., Hu Z; Translational Safety & Bioanalytical Science, Amgen Inc, Thousand Oaks, California, USA., Kulagina N; Pharmaceutical Development Services, Smithers, Gaithersburg, Maryland, USA., Kumar S; DMPK and Bioanalysis, Pioneering Medicines at Flagship Pioneering, Cambridge, Massachusetts, USA., Lai CH; Bioanalytical Sciences, Regeneron Pharmaceuticals, Tarrytown, New York, USA., Lichtfuss M; Research and Clinical Bioanalytics, CSL, Melbourne, Australia., Liu HY; Janssen Research & Development LLC, Spring House, Montgomery County, Pennsylvania, USA., Liu S; Clinical Pharmacology, Biologics & Immunogenicity Clinical Assay Group, Pfizer Inc, Kirkland, Quebec, Canada., Mozaffari R; Bioanalysis, Immunogenicity & Biomarkers (BIB), IVIVT, Research, GSK, Collegeville, Pennsylvania, USA., Pan L; Takeda Development Center Americas Inc, Cambridge, Massachusetts, USA., Pennucci J; Bioanalytical Sciences, Moderna, Cambridge, Massachusetts, USA., Poupart ME; Charles River Laboratories, Senneville, Quebec, Canada., Saini G; Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Snoeck V; Translational Biomarkers and Bioanalysis, UCB Biopharma SRL, 1420, Braine-L'Alleud, Belgium., Storey K; Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc, Rahway, New Jersey, USA., Turner A; Pharmaceutical Development Services, Smithers, Gaithersburg, Maryland, USA., Vainshtein I; Discovery and Translational Research, Exelixis, Alameda, California, USA., Verthelyi D; Office of Pharmaceutical Quality Research, Division IV, Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Wala I; Translational Safety and Bioanalytical Sciences, Amgen, Thousand Oaks, California, USA., Yang L; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA., Yang L; Integrated Bioanalysis, AstraZeneca, Gaithersburg, MD, USA.
Publikováno v:
The AAPS journal [AAPS J] 2024 Sep 04; Vol. 26 (5), pp. 98. Date of Electronic Publication: 2024 Sep 04.
Autor:
Jani D; Bioanalytical and Molecular Assays, Moderna, 325 Binney Street, Cambridge, Massachusetts, USA. darshana.jani@modernatx.com., Gunsior M; Translational Sciences, Astria Therapeutics, Boston, Massachusetts, USA., Marsden R; Revelation Biosciences, San Diego, California, USA., Cowan KJ; Drug Metabolism & Pharmacokinetics, New Biological Entities, Merck KGaA, Darmstadt, Germany., Irvin SC; Bioanalytical Sciences, Regeneron Pharmaceuticals, Tarrytown, New York, USA., Hay LS; Bioanalytical Lab, PPD Clinical Research Business, Thermo Fisher Scientific, Richmond, Virginia, USA., Ward B; Bioanalytical Lab, PPD Clinical Research Business, Thermo Fisher Scientific, Richmond, Virginia, USA., Armstrong L; Bioanalytical Operations, BioAgilytix Labs, Durham, North Carolina, USA., Azadeh M; Bioanalytical and Biomarker Development, Ultragenyx Pharmaceutical, Inc, Novato, California, USA., Cao L; Biomarker and BioAnalytical Sciences, Sangamo Therapeutics, Brisbane, California, USA., Carmean R; Bioanalytical Lab, PPD Clinical Research Business, Thermo Fisher Scientific, Richmond, Virginia, USA., DelCarpini J; Bioanalytical Sciences, Moderna, Cambridge, Massachusetts, USA., Dholakiya SL; Non-Clinical Disposition and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA., Hays A; Scientific Office, BioAgilytix Labs, Durham, North Carolina, USA., Hosback S; Research and Clinical Bioanalytics, CSL, Melbourne, Australia., Hu Z; Translational Safety & Bioanalytical Science, Amgen Inc, Thousand Oaks, California, USA., Kulagina N; Pharmaceutical Development Services, Smithers, Gaithersburg, Maryland, USA., Kumar S; DMPK and Bioanalysis, Pioneering Medicines at Flagship Pioneering, Cambridge, Massachusetts, USA., Lai CH; Bioanalytical Sciences, Regeneron Pharmaceuticals, Tarrytown, New York, USA., Lichtfuss M; Research and Clinical Bioanalytics, CSL, Melbourne, Australia., Liu HY; Janssen Research & Development LLC, Spring House, Montgomery County, Pennsylvania, USA., Liu S; Clinical Pharmacology, Biologics & Immunogenicity Clinical Assay Group, Pfizer Inc, Kirkland, Quebec, Canada., Mozaffari R; Bioanalysis, Immunogenicity & Biomarkers (BIB), IVIVT, Research, GSK, Collegeville, Pennsylvania, USA., Pan L; Takeda Development Center Americas Inc, Cambridge, Massachusetts, USA., Pennucci J; Bioanalytical Sciences, Moderna, Cambridge, Massachusetts, USA., Poupart ME; Immunology, Charles River Laboratories, Senneville, Quebec, Canada., Saini G; Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Snoeck V; Translational Biomarkers and Bioanalysis, UCB Biopharma SRL, 1420, Braine-L'Alleud, Belgium., Storey K; Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc, Rahway, New Jersey, USA., Turner A; Pharmaceutical Development Services, Smithers, Gaithersburg, Maryland, USA., Vainshtein I; Discovery and Translational Research, Exelixis, Alameda, California, USA., Verthelyi D; Office of Pharmaceutical Quality Research, Division IV, Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Wala I; Translational Safety and Bioanalytical Sciences, Amgen, Thousand Oaks, California, USA., Yang L; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA., Yang L; Bioanalytical Sciences, REGENXBIO Inc, Rockville, Maryland, USA.
Publikováno v:
The AAPS journal [AAPS J] 2024 Jul 12; Vol. 26 (4), pp. 80. Date of Electronic Publication: 2024 Jul 12.
Autor:
Jani D; Bioanalytical and Molecular Assays, Moderna, Cambridge, Massachusetts, USA. Darshana.jani@modernatx.com., Marsden R; Revelation Biosciences, California, USA., Gunsior M; Research and Translational Sciences, Astria Therapeutics, Boston, Massachusetts, USA., Hay LS; Bioanalytical Lab, PPD Clinical Research Services, Thermo Fisher Scientific, Richmond, Virginia, USA., Ward B; Bioanalytical Lab, PPD Clinical Research Services, Thermo Fisher Scientific, Richmond, Virginia, USA., Cowan KJ; New Biological Entities Drug Metabolism and Pharmacokinetics, Merck KGaA, Darmstadt, Germany., Azadeh M; Biomarker Operations, Translational Medicine and Early Stage Clinical Development, Alkermes, Inc., Waltham, Massachusetts, USA., Barker B; Drug Metabolism and Biopharmaceuticals, Incyte Corporation, Wilmington, Delaware, USA., Cao L; Biomarker and BioAnalytical Sciences, Sangamo Therapeutics, California, USA., Closson KR; Laboratory Operations, Immunologix Laboratories, Tampa, Florida, USA., Coble K; DMPK/Bioanalytical Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA., Dholakiya SL; Non-Clinical Disposition and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA., Dusseault J; Laboratory Sciences, Charles River Laboratories, Quebec, Canada., Hays A; BioAgilytix, Durham, North Carolina, USA., Herl C; Clinical Pharmacology and Translational Sciences, Exelixis, Alameda, California, USA., Hodsdon ME; Laboratory for Experimental Medicine, Eli Lilly and Company, Indianapolis, Indiana, USA., Irvin SC; Bioanalytical Sciences, Regeneron Pharmaceuticals, Tarrytown, New York, USA., Kirshner S; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Kolaitis G; Non-Clinical Disposition and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA., Kulagina N; Pharmaceutical Development Services, Smithers, Gaithersburg, Maryland, USA., Kumar S; EMD Serono Research and Development Institute (A business of Merck KGaA, Darmstadt, Germany), Billerica, Massachusetts, USA., Lai CH; Bioanalytical Sciences, Regeneron Pharmaceuticals, Tarrytown, New York, USA., Lipari F; Nexelis, a Q2 Solutions Company, Vaccine Sciences, Laval, Quebec, Canada., Liu S; Global Product Development, Clinical Assay Group, Pfizer Inc., Kirkland, Quebec, Canada., Merdek KD; Biomarkers and Clinical Bioanalyses (TMED), Sanofi, Framingham, Massachusetts, USA., Moldovan IR; Cellular Technology Limited (CTL), Shaker Heights, Ohio, USA., Mozaffari R; Bioanalysis, Immunogenicity and Biomarkers (BIB), IVIVT, Research, GSK, Collegeville, Pennsylvania, USA., Pan L; Clinical Biomarker Innovation and Development, Takeda Development Center Americas Inc., Cambridge, Massachusetts, USA., Place C; DMPK/Bioanalytical Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA., Snoeck V; Translational Biomarkers and Bioanalysis, UCB Biopharma SRL, Braine-l'Alleud, Belgium., Manning MS; Translational Safety and Bioanalytical Sciences, Amgen Inc., Thousand Oaks, California, USA., Stocker D; Non-Clinical Disposition and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA., Tary-Lehmann M; Cellular Technology Limited, Department Contract Laboratory, Shaker Heights, Ohio, USA., Turner A; Pharmaceutical Development Services, Smithers, Gaithersburg, Maryland, USA., Vainshtein I; Clinical Pharmacology and Translational Sciences, Exelixis, Alameda, California, USA., Verthelyi D; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Williams WT; Bioanalytical Operations, BioAgilytix Labs, Durham, North Carolina, USA., Yan H; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Yan W; Department of Bioanalytical Sciences, Genentech, South San Francisco, California, USA., Yang L; Clinical Biomarker Innovation and Development, Takeda Development Center Americas Inc., Cambridge, Massachusetts, USA., Yang L; Bioanalytical Sciences, REGENXBIO Inc., Rockville, Maryland, USA., Zemo J; Bioanalytical Operations, BioAgilytix Labs, Durham, North Carolina, USA., Zhong ZD; Development Sciences, Denali Therapeutics, South San Francisco, California, USA.
Publikováno v:
The AAPS journal [AAPS J] 2022 Oct 28; Vol. 24 (6), pp. 113. Date of Electronic Publication: 2022 Oct 28.